Eagle Pharmaceuticals (EGRX) Stock Chart & Stock Price History $3.69 -0.01 (-0.27%) As of 07/22/2025 11:31 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Eagle Pharmaceuticals Stock Price Performance The Eagle Pharmaceuticals (EGRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 31.41%, with a year-to-date return of 638.00%. In the past month, the stock has increased 34.18%, reflecting recent market activity. As of the latest close, Eagle Pharmaceuticals traded at $3.69 with a market cap of $47.92 million and volume of 348 shares. Five years ago, the stock traded at $47.67, representing a 92.26% decrease over that period. At the time, it had a market cap of $662.87 million and a volume of 131,395 shares. Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.27%1 Month Performance+34.18%3 Month Performance+146.00%Year-To-Date Performance+638.00%1 Year Performance-31.41%5 Year Performance-92.26% EGRX Stock Chart for Thursday, July, 24, 2025 EGRX Chart by TradingView Eagle Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/23/2025$3.69$3.69$3.69$2.50348 shs$47.92 million07/22/2025$3.70$3.69-0.27%$3.69$2.50348 shs$47.92 million07/21/2025$3.70$3.70$3.70$2.501,368 shs$48.05 million07/18/2025$3.69$3.70+0.27%$3.70$2.501,368 shs$48.05 million07/17/2025$3.75$3.69-1.60%$3.69$2.901,332 shs$47.92 million07/16/2025$3.74$3.75+0.27%$3.75$2.601,343 shs$48.70 million07/15/2025$3.74$3.74$3.75$2.607,169 shs$48.57 million07/14/2025$3.55$3.74+5.35%$3.75$2.607,169 shs$48.57 million07/11/2025$3.55$3.55$3.58$1.9012,073 shs$46.10 million07/10/2025$3.65$3.55-2.74%$3.58$1.9012,073 shs$46.10 million Get the Latest News and Ratings for EGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/09/2025$3.25$3.65+12.31%$3.87$2.9010,754 shs$47.40 million07/08/2025$3.00$3.25+8.33%$3.25$3.00950 shs$42.21 million07/07/2025$3.00$3.00$3.00$2.36620 shs$38.96 million07/04/2025$3.00$3.00$3.00$2.36620 shs$38.96 million07/03/2025$2.90$3.00+3.63%$3.00$2.36620 shs$38.96 million07/02/2025$2.36$2.90+22.67%$3.00$2.40717 shs$37.60 million07/01/2025$2.90$2.36-18.62%$2.90$2.35823 shs$30.65 million06/30/2025$2.90$2.90$2.95$2.307,821 shs$37.66 million06/27/2025$2.70$2.90+7.41%$2.95$2.307,821 shs$37.66 million06/26/2025$2.70$2.70$2.70$2.301,123 shs$35.07 million06/25/2025$2.75$2.70-1.82%$2.70$2.301,123 shs$35.07 million06/24/2025$2.79$2.75-1.43%$2.75$2.201,546 shs$35.71 million06/23/2025$2.88$2.79-2.96%$2.88$2.102,812 shs$36.23 million Related Companies CTMX Stock Price Chart SXTC Stock Price Chart VYGR Stock Price Chart KYTX Stock Price Chart GNFT Stock Price Chart DRUG Stock Price Chart GALT Stock Price Chart IMAB Stock Price Chart TLSA Stock Price Chart DERM Stock Price Chart Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EGRX) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eagle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
